Novartis Rolls Out Educational Dinner Meeting Series for GP Dentists
Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications:
An Educational Program for Dental Professionals
East Hanover, NJ, September 25, 2008 — Novartis Pharmaceuticals Corporation today announced the launch of a complimentary dental industry-focused dinner meeting series entitled “Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals.”
The dinner meetings are designed as an adjunct to Novartis’ recently-launched web seminar series and are being offered for dentists who prefer live seminars and the opportunity to interact with the presenters as well as their peers.
A total of ten 2-hour dinner meetings (www.oralhealthdinnermeeting.com) are to be hosted between September and December, and will be presented by a rotating roster of clinicians who are leading experts on this compelling and highly relevant subject.
“Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals” will cover the following topics that every general practice dentist needs to know:
Overview of bisphosphonates and uses in treatment of osteoporosis and metastatic bone disease
Osteonecrosis of the jaw (ONJ) background
ONJ frequency in oncology and osteoporosis patients treated with bisphosphonates
Review of ONJ studies and management
The convenient schedule for the 10 Novartis dinner meetings is as follows:
City Date Time
New Jersey Tues -10/14 7:00 PM
Philadelphia Thurs -10/16 7:00 PM
New York City Tues -10/21 7:00 PM
Boston Thurs -10/23 7:00 PM
Miami Tues -10/28 7:00 PM
Chicago Thurs -10/30 7:00 PM
Detroit Weds -11/05 7:00 PM
Dallas Thurs -11/06 7:00 PM
Los Angeles Weds - 11/12 7:30 PM
San Francisco Thurs -11/13 7:00 PM
For more details and to register for any dinner meeting session of “Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals,” visit
www.oralhealthdinnermeeting.com.
An Educational Program for Dental Professionals
East Hanover, NJ, September 25, 2008 — Novartis Pharmaceuticals Corporation today announced the launch of a complimentary dental industry-focused dinner meeting series entitled “Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals.”
The dinner meetings are designed as an adjunct to Novartis’ recently-launched web seminar series and are being offered for dentists who prefer live seminars and the opportunity to interact with the presenters as well as their peers.
A total of ten 2-hour dinner meetings (www.oralhealthdinnermeeting.com) are to be hosted between September and December, and will be presented by a rotating roster of clinicians who are leading experts on this compelling and highly relevant subject.
“Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals” will cover the following topics that every general practice dentist needs to know:
Overview of bisphosphonates and uses in treatment of osteoporosis and metastatic bone disease
Osteonecrosis of the jaw (ONJ) background
ONJ frequency in oncology and osteoporosis patients treated with bisphosphonates
Review of ONJ studies and management
The convenient schedule for the 10 Novartis dinner meetings is as follows:
City Date Time
New Jersey Tues -10/14 7:00 PM
Philadelphia Thurs -10/16 7:00 PM
New York City Tues -10/21 7:00 PM
Boston Thurs -10/23 7:00 PM
Miami Tues -10/28 7:00 PM
Chicago Thurs -10/30 7:00 PM
Detroit Weds -11/05 7:00 PM
Dallas Thurs -11/06 7:00 PM
Los Angeles Weds - 11/12 7:30 PM
San Francisco Thurs -11/13 7:00 PM
For more details and to register for any dinner meeting session of “Benefits of Bisphosphonate Therapy vs Frequency of Oral Complications: An Educational Program for Dental Professionals,” visit
www.oralhealthdinnermeeting.com.
Comments